FLOW KARYOTYPING: OPTIMIZATION AND CLINICAL EVALUATION
流式核型分析:优化和临床评估
基本信息
- 批准号:3314661
- 负责人:
- 金额:$ 53.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1994-11-30
- 项目状态:已结题
- 来源:
- 关键词:Downs syndrome Prader Willi syndrome aneuploidy chromosome deletion chromosome disorders chromosome translocation clinical biomedical equipment cytogenetics diagnosis design /evaluation embryo /fetus cell /tissue female flow cytometry genetic disorder diagnosis human tissue in situ hybridization karyotype nucleic acid probes prenatal diagnosis sex chromosomes sex linked trait stainings trisomy
项目摘要
The overall objective of this project is to develop and evaluate improved
analytical cytologic techniques for prenatal detection of disease-linked
cytogenetic abnormalities. Emphasis will be on a) improving the speed and
sensitivity with which the loss or gain of chromosomal DNA can be detected
and quantified during analysis of metaphase chromosomes, b) detection of
common cytogenetic abnormalities in interphase cells and c) developing
techniques for cytogenetic analysis using fetal cells isolated from
maternal blood. These objectives will be pursued by:
1) Applying bivariate flow karyotyping to quantification of the extent of
chromosome deletions and duplications as small as 1 Mb. Effort during this
project period will be devoted to further increasing the sensitivity of the
technique and applying it in a series of collaborative studies to
characterize subtle structural aberrations of clinical or molecular
biological importance.
2) Optimizing fluorescence in situ hybridization with chromosome specific
probes for reliable detection and characterization of numerical aberrations
involving chromosomes 21, 18, 13, x and y; segmental duplications
(initially 21q22.3 for Down syndrome) and deletions (initially 15q11-13 for
Prader-Willi syndrome) in metaphase spreads and in interphase nuclei.
3) Developing chromosome-specific probes to support the fluorescence
hybridization studies. Whole-chromosome DNA and ssRNA probes depleted in
repetitive sequences will be generated from chromosome-specific cosmid
libraries. Composite probes for 21q22.3, 15q11-13 and elsewhere will be
generated by starting with "seed" probes already mapped to these regions
and "walking" outward in chromosome-specific cosmid libraries to expand the
regions covered by the composite probes.
4) Continuing efforts to isolate fetal cells from maternal blood for
interphase cytogenetic analysis. Specific projects include: a)
determination of the gestational age within the first trimester at which
the fetal cells are present at highest frequency in maternal
blood,b)determination of the origin of the fetal cells (e.g. leukocytes or
cytotrophoblasts) and c) development of procedures for enrichment of the
fetal cells.
这个项目的总体目标是开发和评价改进的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOE W. GRAY其他文献
JOE W. GRAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOE W. GRAY', 18)}}的其他基金
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
了解微米级和纳米级异质性和阻力的影响
- 批准号:
10166790 - 财政年份:2020
- 资助金额:
$ 53.46万 - 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
- 批准号:
9788351 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
- 批准号:
10005913 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
- 批准号:
10471933 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
- 批准号:
10471935 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
- 批准号:
10005916 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Molecular, Cellular, and Tissue Characterization Unit
分子、细胞和组织表征单元
- 批准号:
10246896 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
转移性乳腺癌和前列腺癌的组学和多维空间图谱
- 批准号:
10246894 - 财政年份:2018
- 资助金额:
$ 53.46万 - 项目类别:
相似海外基金
Prader-Willi syndrome (PWS) gene-domain and AAV miniaturization for gene therapy
Prader-Willi 综合征 (PWS) 基因域和 AAV 小型化用于基因治疗
- 批准号:
10593218 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome
探索 Magel2 缺陷情况下 CART/GPR160 在代谢中的作用:对普瑞德威利综合征的影响
- 批准号:
10642678 - 财政年份:2022
- 资助金额:
$ 53.46万 - 项目类别:
Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome
探索 Magel2 缺陷情况下 CART/GPR160 在代谢中的作用:对普瑞德威利综合征的影响
- 批准号:
10353236 - 财政年份:2022
- 资助金额:
$ 53.46万 - 项目类别:
The role and function of nurses on transitional care for Prader-Willi Syndrome in oral health care
护士在口腔保健中普瑞德威利综合征过渡护理中的作用和作用
- 批准号:
21K10844 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Remodelling of cellular RNA Metabolism during Prader-Willi syndrome
普瑞德-威利综合征期间细胞 RNA 代谢的重塑
- 批准号:
2605096 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Studentship
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
- 批准号:
10156474 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
- 批准号:
10410369 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Epigenome editing of the Prader-Willi syndrome imprinted domain with CRISPR/Cas9
使用 CRISPR/Cas9 对 Prader-Willi 综合征印迹域进行表观基因组编辑
- 批准号:
10550159 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Molecular analysis of Prader-Willi syndrome by model mice
模型小鼠普瑞德-威利综合征的分子分析
- 批准号:
21K07848 - 财政年份:2021
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular underpinnings of Prader-Willi syndrome
普瑞德威利综合征的分子基础
- 批准号:
10013261 - 财政年份:2019
- 资助金额:
$ 53.46万 - 项目类别: